{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T06:33:30Z","timestamp":1776580410911,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,6]],"date-time":"2021-10-06T00:00:00Z","timestamp":1633478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100011369","name":"Royal Australian and New Zealand College of Ophthalmologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011369","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s10792-021-02052-0","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T23:10:50Z","timestamp":1633648250000},"page":"863-870","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diagnostic accuracy of Immulite\u00ae TSI immunoassay for thyroid-associated orbitopathy in patients with recently diagnosed Graves\u2019 hyperthyroidism"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6074-4226","authenticated-orcid":false,"given":"Brandon","family":"Thia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myra B.","family":"McGuinness","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter R.","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jwu Jin","family":"Khong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,6]]},"reference":[{"key":"2052_CR1","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1167\/iovs.14-14002","volume":"55","author":"Y Wang","year":"2014","unstructured":"Wang Y, Smith TJ (2014) Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy. Invest Ophthalmol Vis Sci 55:1735\u20131748. https:\/\/doi.org\/10.1167\/iovs.14-14002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2052_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7010196","author":"N Turck","year":"2018","unstructured":"Turck N, Eperon S, De Los AGM, Ob\u00e9ric A, Ham\u00e9dani M (2018) Thyroid-associated orbitopathy and biomarkers: where we are and what we can hope for the future. Dis Mark. https:\/\/doi.org\/10.1155\/2018\/7010196","journal-title":"Dis Mark"},{"key":"2052_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bjophthalmol-2015-307399","volume":"100","author":"JJ Khong","year":"2016","unstructured":"Khong JJ, McNab AA, Ebeling PR et al (2016) Pathogenesis of thyroid eye disease: review and update on molecular mechanisms. Br J Ophthalmol 100:142\u2013150. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307399","journal-title":"Br J Ophthalmol"},{"key":"2052_CR4","doi-asserted-by":"publisher","first-page":"T29","DOI":"10.1530\/JME-17-0276","volume":"61","author":"M Mohyi","year":"2018","unstructured":"Mohyi M, Smith TJ (2018) 40 Years of IGF1: IGF1 receptor and thyroid-associated ophthalmopathy. J Mol Endocrinol 61:T29\u2013T43. https:\/\/doi.org\/10.1530\/JME-17-0276","journal-title":"J Mol Endocrinol"},{"key":"2052_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.autrev.2012.07.003","volume":"12","author":"R Tozzoli","year":"2012","unstructured":"Tozzoli R, Bagnasco M, Giavarina D et al (2012) TSH receptor autoantibody immunoassay in patients with Graves\u2019 disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis. Autoimmun Rev 12:107\u2013113. https:\/\/doi.org\/10.1016\/j.autrev.2012.07.003","journal-title":"Autoimmun Rev"},{"key":"2052_CR6","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1056\/NEJMra1510030","volume":"375","author":"TJ Smith","year":"2016","unstructured":"Smith TJ, Heged\u00fcs L (2016) Graves\u2019 disease. N Engl J Med 375:1552\u20131565. https:\/\/doi.org\/10.1056\/NEJMra1510030","journal-title":"N Engl J Med"},{"key":"2052_CR7","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1055\/s-0035-1554662","volume":"47","author":"CU Frank","year":"2015","unstructured":"Frank CU, Braeth S, Dietrich JW et al (2015) Bridge technology with TSH receptor chimera for sensitive direct detection of TSH receptor antibodies causing Graves\u2019 disease: analytical and clinical evaluation. Horm Metab Res 47:880\u2013888. https:\/\/doi.org\/10.1055\/s-0035-1554662","journal-title":"Horm Metab Res"},{"key":"2052_CR8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fendo.2016.00103","volume":"7","author":"C Giuliani","year":"2016","unstructured":"Giuliani C, Saji M, Bucci I et al (2016) Bioassays for TSH receptor autoantibodies, from FRTL-5 cells to TSH receptor\u2013LH\/CG receptor chimeras: the contribution of leonard D Kohn. Front Endocrinol (Lausanne) 7:103. https:\/\/doi.org\/10.3389\/fendo.2016.00103","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2052_CR9","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1515\/cclm-2016-0197","volume":"55","author":"R Tozzoli","year":"2017","unstructured":"Tozzoli R, D\u2019Aurizio F, Villalta D et al (2017) Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves\u2019 disease. Clin Chem Lab Med 55:58\u201364. https:\/\/doi.org\/10.1515\/cclm-2016-0197","journal-title":"Clin Chem Lab Med"},{"key":"2052_CR10","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1210\/jc.2015-4294","volume":"101","author":"JJ Khong","year":"2016","unstructured":"Khong JJ, Finch S, Silva CD et al (2016) Risk factors for Graves\u2019 orbitopathy; the Australian thyroid-associated orbitopathy research (ATOR) study. J Clin Endocrinol Metab 101:2711\u20132720. https:\/\/doi.org\/10.1210\/jc.2015-4294","journal-title":"J Clin Endocrinol Metab"},{"key":"2052_CR11","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/01676830802414566","volume":"27","author":"K Mohaseb","year":"2008","unstructured":"Mohaseb K, Linder M, Rootman J et al (2008) Development and validation of a patient symptom questionnaire to facilitate early diagnosis of thyroid-associated orbitopathy in Graves\u2019 disease. Orbit 27:419\u2013425. https:\/\/doi.org\/10.1080\/01676830802414566","journal-title":"Orbit"},{"key":"2052_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1097\/01.iop.0000235499.34867.85","volume":"22","author":"PJ Dolman","year":"2006","unstructured":"Dolman PJ, Rootman J (2006) VISA classification for Graves orbitopathy. Ophthalmic Plast Reconstr Surg 22:319\u2013324. https:\/\/doi.org\/10.1097\/01.iop.0000235499.34867.85","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2052_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000339473","volume":"1","author":"S Kautbally","year":"2012","unstructured":"Kautbally S, Alexopoulou O, Daumerie C et al (2012) Greater efficacy of total thyroidectomy versus radioiodine therapy on hyperthyroidism and thyroid-stimulating immunoglobulin levels in patients with Graves\u2019 disease previously treated with antithyroid drugs. Eur Thyroid J 1:122\u2013128. https:\/\/doi.org\/10.1159\/000339473","journal-title":"Eur Thyroid J"},{"key":"2052_CR14","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s40618-016-0478-9","volume":"39","author":"T Diana","year":"2016","unstructured":"Diana T, W\u00fcster C, Kanitz M et al (2016) Highly variable sensitivity of five binding and two bio-assays for TSH-receptor antibodies. J Endocrinol Invest 39:1159\u20131165. https:\/\/doi.org\/10.1007\/s40618-016-0478-9","journal-title":"J Endocrinol Invest"},{"key":"2052_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000478522","volume":"6","author":"T Diana","year":"2017","unstructured":"Diana T, W\u00fcster C, Olivo PD et al (2017) Performance and specificity of 6 immunoassays for TSH receptor antibodies: a multicenter study. Eur Thyroid J 6:243\u2013249. https:\/\/doi.org\/10.1159\/000478522","journal-title":"Eur Thyroid J"},{"key":"2052_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5114\/ceji.2018.80224","volume":"43","author":"GA Bluszcz","year":"2018","unstructured":"Bluszcz GA, Bednarczuk T, Bartoszewicz Z et al (2018) Clinical utility of TSH receptor antibody levels in Graves\u2019 orbitopathy: a comparison of two TSH receptor antibody immunoassays. Cent Eur J Immunol 43:405\u2013412. https:\/\/doi.org\/10.5114\/ceji.2018.80224","journal-title":"Cent Eur J Immunol"},{"key":"2052_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/0004563217700655","volume":"55","author":"C Autilio","year":"2017","unstructured":"Autilio C, Morelli R, Locantore P et al (2017) Stimulating TSH receptor autoantibodies immunoassay: analytical evaluation and clinical performance in Graves\u2019 disease. Ann Clin Biochem 55:172\u2013177. https:\/\/doi.org\/10.1177\/0004563217700655","journal-title":"Ann Clin Biochem"},{"key":"2052_CR18","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1097\/IOP.0000000000001053","volume":"34","author":"T Diana","year":"2018","unstructured":"Diana T, Kahaly GJ (2018) Thyroid stimulating hormone receptor antibodies in thyroid eye disease: methodology and clinical applications. Ophthalmic Plast Reconstr Surg 34:S13\u2013S19. https:\/\/doi.org\/10.1097\/IOP.0000000000001053","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"2052_CR19","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","volume":"52","author":"MN Gerding","year":"2000","unstructured":"Gerding MN, van der Meer JWC, Broenink M et al (2000) Association of thyrotrophin receptor antibodies with the clinical features of Graves\u2019 ophthalmopathy. Clin Endocrinol (Oxf) 52:267\u2013271. https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00959.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2052_CR20","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1365-2265.2004.02143.x","volume":"61","author":"AK Eckstein","year":"2004","unstructured":"Eckstein AK, Plicht M, Lax H et al (2004) Clinical results of anti-inflammatory therapy in Graves\u2019 ophthalmopathy and association with thyroidal autoantibodies. Clin Endocrinol (Oxf) 61:612\u2013618. https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02143.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2052_CR21","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1210\/jc.2005-2813","volume":"91","author":"AK Eckstein","year":"2006","unstructured":"Eckstein AK, Plicht M, Lax H et al (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves\u2019 ophthalmopathy and help to predict severity and outcome of the disease. J Clin Endocrinol Metab 91:3464\u20133470. https:\/\/doi.org\/10.1210\/jc.2005-2813","journal-title":"J Clin Endocrinol Metab"},{"key":"2052_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1089\/thy.1999.9.1175","volume":"9","author":"DHC Khoo","year":"1999","unstructured":"Khoo DHC, Ho SC, Seah LL et al (1999) The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves\u2019 disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid 9:1175\u20131180. https:\/\/doi.org\/10.1089\/thy.1999.9.1175","journal-title":"Thyroid"},{"key":"2052_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1089\/thy.2000.10.809","volume":"10","author":"JY Noh","year":"2000","unstructured":"Noh JY, Hamada N, Inoue Y et al (2000) Thyroid-Stimulating antibody is related to graves\u2019 ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves\u2019 disease. Thyroid 10:809\u2013813. https:\/\/doi.org\/10.1089\/thy.2000.10.809","journal-title":"Thyroid"},{"key":"2052_CR24","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.3349\/ymj.2013.54.4.1033","volume":"54","author":"SY Jang","year":"2012","unstructured":"Jang SY, Shin DY, Lee EJ et al (2012) Correlation between TSH receptor antibody assays and clinical manifestations of Graves\u2019 orbitopathy. Yonsei Med J 54:1033\u20131039. https:\/\/doi.org\/10.3349\/ymj.2013.54.4.1033","journal-title":"Yonsei Med J"},{"key":"2052_CR25","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s40618-015-0254-2","volume":"38","author":"KA Ponto","year":"2015","unstructured":"Ponto KA, Diana T, Binder H et al (2015) Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy. J Endocrinol Invest 38:769\u2013777. https:\/\/doi.org\/10.1007\/s40618-015-0254-2","journal-title":"J Endocrinol Invest"},{"key":"2052_CR26","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1210\/jc.2009-2470","volume":"95","author":"SD Lytton","year":"2010","unstructured":"Lytton SD, Ponto KA, Kanitz M et al (2010) A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves\u2019 orbitopathy. J Clin Endocrinol Metab 95:2123\u20132131. https:\/\/doi.org\/10.1210\/jc.2009-2470","journal-title":"J Clin Endocrinol Metab"},{"key":"2052_CR27","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/j.ophtha.2011.03.030","volume":"118","author":"KA Ponto","year":"2011","unstructured":"Ponto KA, Kanitz M, Olivo PD et al (2011) Clinical relevance of thyroid-stimulating immunoglobulins in Graves\u2019 ophthalmopathy. Ophthalmology 118:2279\u20132285. https:\/\/doi.org\/10.1016\/j.ophtha.2011.03.030","journal-title":"Ophthalmology"},{"key":"2052_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3341\/kjo.2015.29.4.213","volume":"29","author":"YJ Woo","year":"2014","unstructured":"Woo YJ, Jang SY, Lim THT et al (2014) Clinical association of thyroid stimulating hormone receptor antibody levels with disease severity in the chronic inactive stage of Graves\u2019 orbitopathy. Korean J Ophthalmol 29:213\u2013219. https:\/\/doi.org\/10.3341\/kjo.2015.29.4.213","journal-title":"Korean J Ophthalmol"},{"key":"2052_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/cen.12318","volume":"80","author":"SY Jang","year":"2014","unstructured":"Jang SY, Shin DY, Lee EJ et al (2014) Clinical characteristics of Graves\u2019 orbitopathy in patients showing discrepancy between levels from TBII assays and TSI bioassay. Clin Endocrinol (Oxf) 80:591\u2013597. https:\/\/doi.org\/10.1111\/cen.12318","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2052_CR30","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s40618-018-0945-6","volume":"41","author":"S Seo","year":"2018","unstructured":"Seo S, Robledo MS (2018) Usefulness of TSH receptor antibodies as biomarkers for Graves\u2019 ophthalmopathy: a systematic review. J Endocrinol Invest 41:1457\u20131468. https:\/\/doi.org\/10.1007\/s40618-018-0945-6","journal-title":"J Endocrinol Invest"},{"key":"2052_CR31","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1530\/EJE-18-0039","volume":"178","author":"W Wiersinga","year":"2018","unstructured":"Wiersinga W, \u017darkovi\u0107 M, Bartalena L et al (2018) Predictive score for the development or progression of Graves\u2019 orbitopathy in patients with newly diagnosed Graves\u2019 hyperthyroidism. Eur J Endocrinol 178:635\u2013643. https:\/\/doi.org\/10.1530\/EJE-18-0039","journal-title":"Eur J Endocrinol"},{"key":"2052_CR32","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1089\/ct.2018;30.246-250","volume":"30","author":"J Orgiazzi","year":"2018","unstructured":"Orgiazzi J (2018) A validated tool can predict risk or nonrisk of Graves\u2019 orbitopathy during antithyroid drug treatment of hyperthyroid Graves\u2019 disease. Clin Thyroidol 30:246\u2013250. https:\/\/doi.org\/10.1089\/ct.2018;30.246-250","journal-title":"Clin Thyroidol"},{"key":"2052_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1055\/s-0033-1363193","volume":"122","author":"M Lantz","year":"2014","unstructured":"Lantz M, Planck T, \u00c5sman P et al (2014) Increased TRAb and\/or low anti-TPO titers at diagnosis of Graves\u2019 disease are associated with an increased risk of developing ophthalmopathy after onset. Exp Clin Endocrinol Diabetes 122:113\u2013117. https:\/\/doi.org\/10.1055\/s-0033-1363193","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"2052_CR34","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/eye.2013.120","volume":"27","author":"SY Jang","year":"2013","unstructured":"Jang SY, Shin DY, Lee EJ et al (2013) Relevance of TSH-receptor antibody levels in predicting disease course in Graves\u2019 orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay. Eye (Lond) 27:964\u2013971. https:\/\/doi.org\/10.1038\/eye.2013.120","journal-title":"Eye (Lond)"},{"key":"2052_CR35","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.2741\/4687","volume":"23","author":"SD Lytton","year":"2018","unstructured":"Lytton SD, Schluter A, Banga PJ (2018) Functional diagnostics for thyrotropin hormone receptor autoantibodies bioassays prevail over binding assays. Front Biosci 23:2028\u20132043. https:\/\/doi.org\/10.2741\/4687","journal-title":"Front Biosci"},{"key":"2052_CR36","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1210\/jc.2013-4026","volume":"99","author":"T Diana","year":"2014","unstructured":"Diana T, Brown RS, Bossowski A et al (2014) Clinical relevance of thyroid-stimulating autoantibodies in pediatric Graves\u2019 disease: a multicenter study. J Clin Endocrinol Metab 99:1648\u20131655. https:\/\/doi.org\/10.1210\/jc.2013-4026","journal-title":"J Clin Endocrinol Metab"},{"key":"2052_CR37","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1210\/jc.2016-1220","volume":"101","author":"GJ Kahaly","year":"2016","unstructured":"Kahaly GJ, Diana T, Glang J et al (2016) Thyroid stimulating antibodies are highly prevalent in hashimoto\u2019s thyroiditis and associated orbitopathy. J Clin Endocrinol Metab 101:1998\u20132004. https:\/\/doi.org\/10.1210\/jc.2016-1220","journal-title":"J Clin Endocrinol Metab"},{"key":"2052_CR38","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/cen.12392","volume":"80","author":"JJ Khong","year":"2014","unstructured":"Khong JJ, Goldstein RF, Sanders KM et al (2014) Serum selenium status in Graves\u2019 disease with and without orbitopathy: a case-control study. Clin Endocrinol (Oxf) 80:905\u2013910. https:\/\/doi.org\/10.1111\/cen.12392","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2052_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fendo.2017.00137","volume":"8","author":"I Bucci","year":"2017","unstructured":"Bucci I, Giuliani C, Napolitano G (2017) Thyroid-stimulating hormone receptor antibodies in pregnancy: clinical relevance. Front Endocrinol (Lausanne) 8:137. https:\/\/doi.org\/10.3389\/fendo.2017.00137","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-021-02052-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-021-02052-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T16:48:34Z","timestamp":1647017314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-021-02052-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1007\/s10792-021-02052-0","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,6]]},"assertion":[{"value":"5 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publication"}},{"value":"The study was approved by the Human Research Ethics committee of The Royal Victorian Eye and Ear Hospital (Ethics approval number: 10\/946H\/20).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}